Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulse Biosciences Stock (NASDAQ: PLSE) stock price, news, charts, stock research, profile.
Open4.420 | Close4.030 |
Vol / Avg.206.567K / 177.887K | Mkt Cap221.259M |
Day Range3.890 - 4.470 | 52 Wk Range1.580 - 9.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.190 | 0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-09-21 | Maxim Group | Anthony Vendetti | Downgrades | BuyHold | - | - | - |
2022-05-13 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2022-04-01 | Stephens & Co. | Chris Cooley | Maintains | Overweight | Lowers | 14.00 | 12.00 |
2022-04-01 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | Buy | Lowers | 20.00 | 8.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PLSE | Pulse Biosciences | -7.57% | 221.3M |
AXGN | Axogen | -1.19% | 214.9M |
NPCE | NeuroPace | 4.51% | 251.6M |
SGHT | Sight Sciences | -1.21% | 158.6M |
SMLR | Semler Scientific | -5.58% | 174.4M |
You can purchase shares of Pulse Biosciences (NASDAQ: PLSE) through any online brokerage.
Other companies in Pulse Biosciences’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on Wednesday, September 21, 2022. The analyst firm set a price target for 0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pulse Biosciences (NASDAQ: PLSE) is $4.03 last updated September 29, 2023 at 8:40 PM UTC.
There is no dividend information for Pulse Biosciences.
Pulse Biosciences’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Pulse Biosciences.
Pulse Biosciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.